Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001477932-18-001291
Filing Date
2018-03-14
Accepted
2018-03-14 16:39:30
Documents
48
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K oncx_10k.htm 10-K 729129
2 SECURITIES PURCHASE AGREEMENT oncx_ex102.htm EX-10.2 9699
3 SECURITIES PURCHASE AGREEMENT oncx_ex103.htm EX-10.3 10404
4 CERTIFICATION oncx_ex311.htm EX-31.1 7858
5 CERTIFICATION oncx_ex321.htm EX-32.1 3233
12 oncx_10kimg15.jpg GRAPHIC 24589
  Complete submission text file 0001477932-18-001291.txt   3087787

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT oncx-20171231.xml EX-101.INS 415718
7 XBRL TAXONOMY EXTENSION SCHEMA oncx-20171231.xsd EX-101.SCH 41257
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oncx-20171231_cal.xml EX-101.CAL 28415
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oncx-20171231_def.xml EX-101.DEF 151752
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE oncx-20171231_lab.xml EX-101.LAB 221371
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oncx-20171231_pre.xml EX-101.PRE 198771
Mailing Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014
Business Address 14405 WALTERS ROAD SUITE 780 HOUSTON TX 77014 281-402-3167
Oncolix, Inc. (Filer) CIK: 0001584137 (see all company filings)

EIN.: 463046340 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-55545 | Film No.: 18689935
SIC: 2834 Pharmaceutical Preparations